Literature DB >> 19432873

Macular function after intravitreal triamcinolone acetonide injection for diabetic macular oedema.

Murat Karacorlu1, Hakan Ozdemir, Fevzi Senturk, Serra Arf Karacorlu, Omer Uysal.   

Abstract

PURPOSE: We aimed to evaluate the effect of intravitreal triamcinolone acetonide (IVTA) on macular function in patients with diabetic macular oedema (DMO).
METHODS: Eleven eyes in 11 patients with DMO were enrolled. In each eye, at baseline and at 30 days after IVTA injection, logMAR visual acuity (VA), macular sensitivity, fixation stability and fixation location by MP-1 microperimetry and optical coherence tomography (OCT) foveal thickness were assessed.
RESULTS: Thirty days after IVTA injection, eyes with DMO showed a significant (p<0.001) reduction in foveal thickness and significant (p<0.01) increases in logMAR VA and MP-1 retinal sensitivity (p<0.001). There was also significant (p=0.046) improvement in fixation location and some improvement in fixation stability, although the latter was not significant (p=0.08).
CONCLUSIONS: In eyes with DMO, short-term improvement in retinal sensitivity and fixation properties can be achieved by IVTA injection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19432873     DOI: 10.1111/j.1755-3768.2008.01497.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  7 in total

1.  Geographic pattern of central retinal sensitivity after intravitreal triamcinolone for diabetic macular edema.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.

Authors:  S Sivaprasad; E Pearce; V Chong
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

3.  Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edema.

Authors:  Zübeyir Yozgat; Mustafa Doğan; Mehmet Cem Sabaner; Hamidu Hamisi Gobeka; Serpil Yazgan Akpolat
Journal:  Int Ophthalmol       Date:  2021-02-19       Impact factor: 2.031

4.  Prospective microperimetry and OCT evaluation of efficacy of repeated intravitreal bevacizumab injections for persistent clinically significant diabetic macular edema.

Authors:  Romualdo Malagola; Giovanni Spinucci; Carmela Cofone; Luigi Pattavina
Journal:  Int Ophthalmol       Date:  2012-12-14       Impact factor: 2.031

5.  [Influence of postoperative oral steroid treatment on retinal sensitivity in patients after macular surgery. A randomized, controlled, clinical trial].

Authors:  S Rezar; S Sacu; M Ritter; W Bühl; M Georgopoulos; U Schmidt-Erfurth; C Prünte
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

6.  Retinal ultrastructural, electrophysiological, and microvascular morphological outcomes in diabetic macular edema treated with intravitreal bevacizumab.

Authors:  Furkan Fatih Gulyesil; Sibel Inan; Hamidu Hamisi Gobeka; Mehmet Cem Sabaner; Anar Alizada
Journal:  Ir J Med Sci       Date:  2022-03-23       Impact factor: 1.568

7.  Structure-Function Correlation Using OCT Angiography And Microperimetry In Diabetic Retinopathy.

Authors:  Marta Alonso-Plasencia; Rodrigo Abreu-González; Mario Alberto Gómez-Culebras
Journal:  Clin Ophthalmol       Date:  2019-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.